PDS Biotech is a clinical stage biopharmaceutical company with a growing pipeline of cancer immunotherapies and infectious disease vaccines. Our team is committed to developing first-in-class T cell activating immunotherapies to fight against cancer and to provide more rapid and longer-lasting protection against infectious diseases.
|Proprietary T cell activating platforms
|Ongoing Phase 2 clinical trials
|With Merck, MD Anderson Cancer Center,
National Cancer Institute and Mayo Clinic